| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026 |
Edgewise Therapeutics Inc
EWTX
|
BUY |
$45.00
Est. +52%
|
$29.66 | $40.77 |
Pending
|
$35.21
+18.7%
|
| Feb 24, 2026 |
Vir Biotechnology Inc
VIR
|
BUY |
$18.00
Est. +86%
|
$9.70 | $11.66 |
Pending
|
$8.61
-11.2%
|
| Feb 23, 2026 |
Arcellx Inc
ACLX
|
BUY |
$115.00
Est. +1%
|
$113.81 | $115.13 |
Bullseye Hit (±1%)
|
$115.07
+1.1%
|
| Feb 17, 2026 |
Moderna Inc
MRNA
|
SELL |
$35.00
Est. +19%
|
$43.19 | $41.97 (Low) |
Pending
|
$52.13
-20.7%
|
| Jan 23, 2026 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$530.00
Est. +13%
|
$469.11 | $507.92 |
Pending
|
$450.69
-3.9%
|
| Sep 03, 2025 |
Cytokinetics Inc
CYTK
|
BUY |
$80.00
Est. +60%
|
$49.99 | $80.18 |
Bullseye Hit (±1%)
|
$71.38
+42.8%
|
| Aug 01, 2025 |
Moderna Inc
MRNA
|
BUY |
$32.00
Est. +8%
|
$29.56 | $59.55 |
Target Met
|
$52.13
+76.4%
|
| Nov 19, 2024 |
BioNTech SE - ADR
BNTX
|
BUY |
$125.00
Est. +55%
|
$80.80 | $129.27 |
Target Met
|
$90.80
+12.4%
|
| Oct 31, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$1,170.00
Est. +40%
|
$838.20 | $882.84 |
Miss
|
$614.65
-26.7%
|
| Oct 29, 2024 |
Arcellx Inc
ACLX
|
BUY |
$120.00
Est. +41%
|
$84.99 | $107.37 |
Miss
|
$115.07
+35.4%
|
| Oct 24, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$1,175.00
Est. +25%
|
$941.39 | $950.47 |
Miss
|
$614.65
-34.7%
|
| Sep 12, 2024 |
Moderna Inc
MRNA
|
BUY |
$105.00
Est. +55%
|
$67.68 | $75.36 |
Miss
|
$52.13
-23.0%
|
| Aug 06, 2024 |
Biomarin Pharmaceutical Inc. - Registered Shares
BMRN
|
BUY |
$115.00
Est. +34%
|
$85.99 | $94.85 |
Miss
|
$55.65
-35.3%
|
| May 13, 2024 |
BridgeBio Pharma Inc
BBIO
|
BUY |
$50.00
Est. +75%
|
$28.50 | $39.54 |
Miss
|
$68.00
+138.6%
|
| May 13, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$1,150.00
Est. +18%
|
$976.96 | $1,211.20 |
Target Met
|
$614.65
-37.1%
|
| May 13, 2024 |
Biomarin Pharmaceutical Inc. - Registered Shares
BMRN
|
BUY |
$113.00
Est. +40%
|
$80.50 | $94.85 |
Miss
|
$55.65
-30.9%
|
| May 13, 2024 |
Neurocrine Biosciences, Inc.
NBIX
|
BUY |
$175.00
Est. +29%
|
$136.15 | $157.98 |
Miss
|
$159.51
+17.2%
|
| May 13, 2024 |
BioNTech SE - ADR
BNTX
|
BUY |
$100.00
Est. +8%
|
$92.72 | $131.49 |
Target Met
|
$90.80
-2.1%
|
| May 13, 2024 |
Moderna Inc
MRNA
|
SELL |
$120.00
Est. +5%
|
$125.67 | $23.15 (Low) |
Target Met
|
$52.13
+58.5%
|
| May 13, 2024 |
Arcellx Inc
ACLX
|
BUY |
$85.00
Est. +71%
|
$49.77 | $107.37 |
Target Met
|
$115.07
+131.2%
|
| Feb 04, 2022 |
Regeneron Pharmaceuticals, Inc.
REGN
|
SELL |
$604.00
Est. +3%
|
$622.96 | - | - |
$614.65
+1.3%
|
| Feb 03, 2022 |
Biogen Inc
BIIB
|
BUY |
$236.00
Est. +7%
|
$220.17 | - | - |
$198.64
-9.8%
|
| Jan 27, 2022 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$288.00
Est. +26%
|
$228.22 | - | - |
$450.69
+97.5%
|
| Nov 19, 2021 |
Bluebird bio Inc
BLUE
|
BUY |
$14.00
Est. +31%
|
$10.70 | $234.00 |
Target Met
|
$4.97
-53.6%
|
| Nov 04, 2021 |
Moderna Inc
MRNA
|
SELL |
$165.00
Est. +42%
|
$284.02 | - | - |
$52.13
+81.6%
|
| Aug 04, 2021 |
Acadia Pharmaceuticals Inc
ACAD
|
BUY |
$34.00
Est. +62%
|
$21.05 | - | - |
$21.27
+1.0%
|
| Apr 29, 2021 |
Gilead Sciences, Inc.
GILD
|
BUY |
$74.00
Est. +21%
|
$61.14 | - | - |
$124.30
+103.3%
|